ICM
KLRS

Irenic Capital Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Irenic Capital Management’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-112,156
Closed -$1.95M – 26
2024
Q1 		$1.95M Buy
+112,156
New +$1.95M 0.4% 17